BRKR Bruker Corporation featured news, full reports, and detailed charts
Bruker Corporation (BRKR) Wrap Up:
We design, manufacture, service and market analytical and life science systems and associated products to address the rapidly evolving needs of our customers in life science research, pharmaceutical, biotechnology and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. As of December 31, 2007, the period end for which this Annual Report on Form 10-K is being filed, Bruker BioSciences Corporation was the publicly traded parent company of Bruker AXS Inc., Bruker Daltonics Inc. and Bruker Optics Inc. On February 26, 2008, Bruker BioSciences Corporation closed its acquisition of the Bruker BioSpin Group, and renamed itself Bruker Corporation. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f17%2f0001047469-08-002906.html#FIS_BUSINESS"Bruker Corporation (BRKR:NASDAQ)
Snapshot of Bruker Corporation (BRKR)
|
OPEN
$11.30
|
PREVIOUS CLOSE
$11.42
|
|
|
DAY HIGH
$11.84
|
DAY LOW
$11.30
|
|
|
52 WEEK HIGH
11/20/09 - $11.84
|
52 WEEK LOW
11/21/08 - $3.07
|
|
|
MARKET CAP
1.9B
|
AVERAGE VOLUME 3 mo
395.3K
|
|
|
DILUTED EPS TTM
$0.39
|
SHARES OUTSTANDING
164.2M
|
|
|
BRKR Does Not Pay Dividends
|
P/E TTM
29.8x
|
|
| K = Thousands M = Millions B = Billions | ||
BRKR Top Compensated Officers
Executives, Board Directors
Key developments for Bruker Corporation (BRKR)
Effective November 11, 2009, Dirk D. Laukien, Ph.D. has elected to resign from his position as Senior Vice President of Bruker Corporation and from the following executive management and directorship positions at subsidiaries of the company: President of Bruker Optics Inc.; Co-President and director of Bruker BioSpin Corporation; and director of Bruker BioSpin AG. Additionally, Dr. Dirk Laukien has elected to resign from his position as Co-Chief Executive Officer of the worldwide Bruker BioSpin group of companies, to be effective February 1, 2010. Dr. Dirk Laukien has tendered his resignation from these positions in order to have more time to devote to personal interests. Dr. Dirk Laukien will remain with the company as Senior Scientific Fellow and will continue his service on the company's board of directors.
Bruker Corporation - Conference Presentation Calls
Bruker Corporation announced that its Board of Directors has appointed Bill Knight to Chief Operating Officer (COO) and Brian Monahan to Chief Financial Officer (CFO), with an effective date of February 1st, 2010. Presently, Bill Knight is serving as CFO, and Brian Monahan is serving as Chief Accounting Officer of Bruker Corporation. Mr. Knight joined Bruker Corporation as CFO and Treasurer in October 2004. At Bruker, Mr. Knight is also the President of the Bruker Detection business in the United States. Before joining the company, Mr. Knight served as an operations-focused CFO in several public companies, and was a founder of ATI Technologies, an analytical instruments company where he had both financial and operational responsibilities. Mr. Monahan joined Bruker Corporation as the Corporate Controller in April 2004 and was appointed Chief Accounting Officer and Vice President of Finance in March 2009. Before joining the company, from 2002 through 2004, Mr. Monahan served as the Manager of Accounting and Financial Reporting at Fisher Scientific International Inc., and as an audit manager for PricewaterhouseCoopers LLP from 1999 through 2002.
BRKR Competitors
| Company | Last | Change |
| JEOL Ltd | ¥324.00 JPY | 0.00 |
| MDS Inc | C$8.17 CAD | +0.01 |
| PerkinElmer Inc | $19.04 USD | -0.32 |
| Varian Inc | $51.06 USD | +0.04 |
| Waters Corp | $59.04 USD | -0.33 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | BRKR | Industry Range |
| Price/Earnings | 29.5x |
|
| Price/Sales | 1.8x |
|
| Price/Book | 5.0x |
|
| Price/Cash Flow | 29.3x |
|
| TEV/Sales | 1.5x |
|
|
BRKR |
||
BRKR transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
